'Gastric cancer' diaporamas de présentation

Genome-Wide Mutational Analyses of Human Cancers: Lessons Learned From Sequencing Cancer Genomes

Genome-Wide Mutational Analyses of Human Cancers: Lessons Learned From Sequencing Cancer Genomes. Will Parsons, M.D., Ph.D. Ludwig Center for Cancer Genetics and Therapeutics The Sidney Kimmel Cancer Center Johns Hopkins University Sept 5, 2008. Overview.

848 views • 59 slides

Treatment of advanced Metastatic Gastric Cancer:

Treatment of advanced Metastatic Gastric Cancer:. Ofer Purim Chief Gastrointestinal Malignancy Service Assuta Samson Hospital Ashdod, Israel. PP-RB-IL-0019. Gastric cancer: a global disease. 4th most common malignant disease ~ 930,000

2.46k views • 56 slides

Management of stomach cancer: Medical O ncology perspective

Management of stomach cancer: Medical O ncology perspective. Presenter: Dr. Md Shahriar Kabir MD ( Thesis ) Medical Oncology NICRH. Stomach Cancer of USA in 2019. A bout 27,510 new cases will be diagnosed in 2019 17,230 of them will be male and 10,280 are female.

1.11k views • 53 slides

International Health Care Management Part 2b

947 views • 52 slides

Gastrointestinal Bleeding

Gastrointestinal Bleeding. Rajeev Jain, M.D. GI Bleeding. Background Acute Upper GI Bleed Acute Lower GI Bleed . Clinical Presentation Definitions. Hematemesis: bloody vomitus (bright red or coffee-grounds) Melena: black, tarry, foul-smelling stool

995 views • 48 slides

Cancer Genetics

Cancer Genetics. Jason P. Wilson, MD, MBA, FACS Deena Wahba, MSc, CGC. I have no disclosures. Objectives. Provide Examples of Genetic Testing in Clinical Practice Describe Current State of Genetic Testing Provide Guidance on When to Refer patients for Genetic Testing

1.26k views • 47 slides

Charles S. Fuchs, MD Dana-Farber Cancer Institute Harvard Medical School Boston, MA

Will targeting the VEGF-receptor prove to be any more successful in gastroesophageal adenocarcinoma than did targeting its ligand VEGF?. Charles S. Fuchs, MD Dana-Farber Cancer Institute Harvard Medical School Boston, MA. VEGF-Mediated Signaling. PlGF. VEGF-A. VEGF-B. VEGF-C. VEGF-D.

571 views • 44 slides

Polyclonal Antibody Stimulator (PAS) A Phase III Ready Anti-Gastrin Vaccine Cancer Advances Inc.

Polyclonal Antibody Stimulator (PAS) A Phase III Ready Anti-Gastrin Vaccine Cancer Advances Inc. Vaccicure Limited. Non-Confidential Introduction 2019. Executive Summary.

428 views • 42 slides

Chapter 78

Chapter 78. Drugs for Peptic Ulcer Disease. Peptic Ulcer Disease. Definition Group of upper GI disorders Degrees of erosion of the gut wall Severe erosion can be complicated by hemorrhage and perforation Cause Imbalance between mucosal and aggressive factors .

621 views • 36 slides

Presented by Mihaela C. Badea-Mic

Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: A strategy for bacterial survival. Alain P. Gobert, David J. McGee, Mahmood Akhtar, George L. Mendz, Jamie C. Newton, Yulan Cheng, Harry L. T. Mobley, and Keith T. Wilson. Presented by Mihaela C. Badea-Mic.

492 views • 31 slides

?????? ???? ?? ??? ????? ?????? ???.

??? ???? ?????? ??????. ?????? ???? ?? ??? ????? ?????? ???. . ?????? ???? (?) ?? ??????? :. Lecture 6: CT scan Abdomen & Pelvic. Computer Tomography Technique . Prepared by: Behzad Ommani Master of Medical Engineering Instructor Radiology Group. September , 2012. Oral Contrast.

422 views • 30 slides

397 views • 22 slides

Gastric Cancer Epidemiology

Gastric Cancer Epidemiology. Suminori Kono, MD, PhD Professor of Preventive Medicine Kyushu Univ School of Medicine Fukuoka 812-8582, Japan skono@phealth.med.kyushu-u.ac.jp. Learning Objectives. Understand descriptive features Learn protective and risk factors

501 views • 20 slides

475 views • 20 slides

Evidence-based Counseling for GI Malignancy Risk Reduction

Evidence-based Counseling for GI Malignancy Risk Reduction. Mark Y. Liu, DO, FAAFP Tripler Army Medical Center Honolulu, Hawaii.

725 views • 19 slides

SAGES Go Global

SAGES Go Global. Praia, Cape Verde. Kevin McGill, MD; Fellow, Division of Minimally Invasive Surgery. Go Global.

251 views • 14 slides

Cancer Wellness Center May 13, 2010 Anne Leavell, MS, RD, LDN, CDE Department of Neurology, Northwestern Medical Facult

Supplements For Your Nervous System. Cancer Wellness Center May 13, 2010 Anne Leavell, MS, RD, LDN, CDE Department of Neurology, Northwestern Medical Faculty Foundation. Supplements. Disclaimer:

273 views • 7 slides

Cancer Wellness Center May 13, 2010 Anne Leavell, MS, RD, LDN, CDE Department of Neurology, Northwestern Medical Facult

Supplements For Your Nervous System. Cancer Wellness Center May 13, 2010 Anne Leavell, MS, RD, LDN, CDE Department of Neurology, Northwestern Medical Faculty Foundation. Supplements. Disclaimer:

214 views • 7 slides

Stomach Cancer - Drug Pipeline Analysis and Market to 2016

The Gastric Cancer Market is Forecast to Show Strong Growth Until 2016

514 views • 4 slides

Introduction

Numerous older studies have reported the association between Billroth II (BII) and Gastric Cancer / Gastric Stump Cancer (GCa) 20 -30 years post surgery.

171 views • 1 slides